Home › Asset managers › TIAA › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal TIAA voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,146 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | TIAA voted | Funds |
|---|---|---|---|---|---|---|---|
| CPFL ENERGIA SA | April 29, 2025 | Percentage of Votes to Be Assigned - Elect Claudia Elisa de Pinho Soares as Independent Director | Director Elections | Board | ABSTAIN | 2 | |
| CPFL ENERGIA SA | April 29, 2025 | Percentage of Votes to Be Assigned - Elect Daobiao Chen as Director | Director Elections | Board | ABSTAIN | 2 | |
| CPFL ENERGIA SA | April 29, 2025 | Percentage of Votes to Be Assigned - Elect Gustavo Estrella as Director | Director Elections | Board | ABSTAIN | 2 | |
| CPFL ENERGIA SA | April 29, 2025 | Percentage of Votes to Be Assigned - Elect Kedi Wang as Director | Director Elections | Board | ABSTAIN | 2 | |
| CPFL ENERGIA SA | April 29, 2025 | Percentage of Votes to Be Assigned - Elect Yumeng Zhao as Director | Director Elections | Board | ABSTAIN | 2 | |
| CPFL ENERGIA SA | April 29, 2025 | Percentage of Votes to Be Assigned - Elect Yusheng Wang as Director | Director Elections | Board | ABSTAIN | 2 | |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Glenda J. Flanagan | Director Elections | Board | WITHHOLD | 2 | |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Scott J. Vassalluzzo | Director Elections | Board | WITHHOLD | 2 | |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Thomas N. Tryforos | Director Elections | Board | WITHHOLD | 2 | |
| CREDIT ACCEPTANCE CORP. | June 4, 2025 | Election of Directors: Vinayak R. Hegde | Director Elections | Board | WITHHOLD | 2 | |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Arrangement of Guarantees | Capital Structure | Board | AGAINST | 2 | |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Debt Financing Instruments | Capital Structure | Board | AGAINST | 2 | |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights for Additional A Shares and H Shares | Capital Structure | Board | AGAINST | 2 | |
| CSI SOLAR CO. LTD. | May 28, 2025 | Approve Remuneration of Directors and Senior Management | Compensation | Board | AGAINST | 2 | |
| CSI SOLAR CO. LTD. | May 28, 2025 | Approve Remuneration of Supervisors | Compensation | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds | Capital Structure | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Price and Payment Method | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Use of Proceeds | Capital Structure | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) | Extraordinary Transactions | Board | AGAINST | 2 | |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | April 15, 2025 | Approve Use of Idle Raised Funds and Own Funds for Cash Management | Extraordinary Transactions | Board | AGAINST | 2 | |
| CTBC FINANCIAL HOLDING CO. LTD. | June 13, 2025 | Approve Issuance of Restricted Stocks | Compensation | Board | AGAINST | 2 | |
| CTS EVENTIM AG & CO. KGAA | May 21, 2025 | Elect Philipp Westermeyer to the Supervisory Board | Director Elections | Board | AGAINST | 2 | |
| CTS Eventim AG & Co. KGaA | May 21, 2025 | Elect Philipp Westermeyer to the Supervisory Board | Director Elections | Board | AGAINST | 2 | |
| CUBESMART | May 20, 2025 | Election of Trustees: Piero Bussani | Director Elections | Board | WITHHOLD | 2 | |
| CURTISS-WRIGHT CORP. | May 8, 2025 | Election of Directors: Dean M. Flatt | Director Elections | Board | WITHHOLD | 2 | |
| CURTISS-WRIGHT CORP. | May 8, 2025 | Election of Directors: Peter C. Wallace | Director Elections | Board | WITHHOLD | 2 | |
| CUSTOMERS BANCORP INC. | May 27, 2025 | Election of Directors: Andrea R. Allon | Director Elections | Board | AGAINST | 2 | |
| CUSTOMERS BANCORP INC. | May 27, 2025 | Election of Directors: Daniel K. Rothermel | Director Elections | Board | AGAINST | 2 | |
| Cardlytics, Inc. | May 20, 2025 | Advisory vote to approve compensation of named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| Cardlytics, Inc. | May 20, 2025 | Approval of the Cardlytics, Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 2 | |
| Carlsberg A/S | March 17, 2025 | Approve Remuneration Report (Advisory Vote) | Compensation | Board | AGAINST | 2 | |
| Carlsberg A/S | March 17, 2025 | Elect Jens Hjorth as New Director | Director Elections | Board | ABSTAIN | 2 | |
| Carlsberg A/S | March 17, 2025 | Reelect Majken Schultz as Director | Director Elections | Board | ABSTAIN | 2 | |
| Carrefour SA | May 28, 2025 | Approve Compensation of Alexandre Bompard, Chairman and CEO | Compensation | Board | AGAINST | 2 | |
| Carrefour SA | May 28, 2025 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 165 Million | Capital Structure | Board | AGAINST | 2 | |
| Carrefour SA | May 28, 2025 | Authorize Board to Increase Capital in the Event of Additional Demand Related to Delegation Submitted to Shareholder Vote Under Items 15 to 17 | Capital Structure | Board | AGAINST | 2 | |
| Carrefour SA | May 28, 2025 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 165 Million | Capital Structure | Board | AGAINST | 2 | |
| Cartesian Therapeutics, Inc. | June 13, 2025 | Election of Directors: Timothy C. Barabe, MBA | Director Elections | Board | WITHHOLD | 2 | |
| Chemung Financial Corporation | June 3, 2025 | Election of Directors: Robert H. Dalrymple | Director Elections | Board | WITHHOLD | 2 | |
| Chemung Financial Corporation | June 3, 2025 | To approve the Chemung Financial Corporation 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 2 | |
| Citi Trends, Inc. | June 5, 2025 | Election of Directors: Pamela Edwards | Director Elections | Board | AGAINST | 2 | |
| Citi Trends, Inc. | June 5, 2025 | Vote to approve an Amendment to the 2021 Incentive Plan to increase the number of shares available by 500,000 for grant. | Compensation | Board | AGAINST | 2 | |
| Citizens Financial Services, Inc. | April 15, 2025 | Election of Class 2 Directors: Christopher W. Kunes | Director Elections | Board | WITHHOLD | 2 | |
| Citizens Financial Services, Inc. | April 15, 2025 | Election of Class 2 Directors: Thomas E. Freeman | Director Elections | Board | WITHHOLD | 2 | |
| Coloplast A/S | December 5, 2024 | Reelect Niels Peter Louis-Hansen as Director | Director Elections | Board | ABSTAIN | 2 | |
| Commercial Vehicle Group, Inc. | May 15, 2025 | A non-binding advisory vote on the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 2 | |
| CompX International Inc. | May 21, 2025 | Director Nominees: Ann Manix | Director Elections | Board | WITHHOLD | 2 | |
| CompX International Inc. | May 21, 2025 | Director Nominees: Gina A. Norris | Director Elections | Board | WITHHOLD | 2 | |
| CompX International Inc. | May 21, 2025 | Director Nominees: Loretta J. Feehan | Director Elections | Board | WITHHOLD | 2 | |
| CompX International Inc. | May 21, 2025 | Director Nominees: Mary A. Tidlund | Director Elections | Board | WITHHOLD | 2 | |
| CompX International Inc. | May 21, 2025 | Director Nominees: Terri L. Herrington | Director Elections | Board | WITHHOLD | 2 | |
| CompX International Inc. | May 21, 2025 | Director Nominees: Thomas E. Barry | Director Elections | Board | WITHHOLD | 2 | |
| Consumer Portfolio Services, Inc. | November 12, 2024 | Election of Directors: Brian J. Rayhill | Director Elections | Board | WITHHOLD | 2 | |
| Consumer Portfolio Services, Inc. | November 12, 2024 | Election of Directors: Gregory S. Washer | Director Elections | Board | WITHHOLD | 2 | |
| Consumer Portfolio Services, Inc. | November 12, 2024 | Election of Directors: William W. Grounds | Director Elections | Board | WITHHOLD | 2 | |
| Contango ORE, Inc. | June 10, 2025 | Election of Directors: Brad Juneau | Director Elections | Board | WITHHOLD | 2 | |
| Contango ORE, Inc. | June 10, 2025 | Election of Directors: Darwin Green | Director Elections | Board | WITHHOLD | 2 | |
| Contango ORE, Inc. | June 10, 2025 | Election of Directors: Richard A. Shortz | Director Elections | Board | WITHHOLD | 2 | |
| Contango ORE, Inc. | June 10, 2025 | Election of Directors: Rick Van Nieuwenhuyse | Director Elections | Board | WITHHOLD | 2 | |
| Contemporary Amperex Technology Co., Ltd. | April 8, 2025 | Approve Estimated Amount of Guarantees | Capital Structure | Board | AGAINST | 2 | |
| D'IETEREN GROUP | December 6, 2024 | Approve Dividends | Capital Structure | Board | AGAINST | 2 | |
| D'Ieteren Group | December 6, 2024 | Approve Dividends | Capital Structure | Board | AGAINST | 2 | |
| DAIWA SECURITIES GROUP INC. | June 20, 2025 | Elect Director Nakata, Seiji | Director Elections | Board | AGAINST | 2 | |
| DAIWA SECURITIES GROUP INC. | June 20, 2025 | Elect Director Ogino, Akihiko | Director Elections | Board | AGAINST | 2 | |
| DAQIN RAILWAY CO. LTD. | May 21, 2025 | Approve to Authorize the Board of Directors to Decide on the Company's Interim Profit Distribution | Capital Structure | Board | AGAINST | 2 | |
| DAR AL ARKAN REAL ESTATE DEVELOPMENT CO. | June 29, 2025 | Elect Abdullah Sharbeeni as Director | Director Elections | Board | ABSTAIN | 2 | |
| DAR AL ARKAN REAL ESTATE DEVELOPMENT CO. | June 29, 2025 | Elect Abdulrahman Al Musnid as Director | Director Elections | Board | ABSTAIN | 2 | |
| DAR AL ARKAN REAL ESTATE DEVELOPMENT CO. | June 29, 2025 | Elect Abdulrahman Bajuniyd as Director | Director Elections | Board | ABSTAIN | 2 | |
| DAR AL ARKAN REAL ESTATE DEVELOPMENT CO. | June 29, 2025 | Elect Badr Al Ghuneem as Director | Director Elections | Board | ABSTAIN | 2 | |
| DAR AL ARKAN REAL ESTATE DEVELOPMENT CO. | June 29, 2025 | Elect Fahd Al Ajmi as Director | Director Elections | Board | ABSTAIN | 2 |
← Previous Page 35 of 62 Next →
← Back to TIAA 2024-2025 overview
Built November 1, 2026 from SEC Form N-PX filings.